A recent study published in CHEST found that treatment-naïve adults with obesity-hypoventilation syndrome receiving a combination of acetazolamide and atomoxetine for 2 weeks had improved ...
A 2026 informational overview examining how MyoGlow's LED, electroporation, thermal, and sonic massage technology positioning ...
NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and ...
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving ILUVIEN ® (fluocinolone acetonide intravitreal ...
Paul Pogba is available for AS Monaco in its Ligue 1 matchup against Marseille on Sunday. The former France international has ...
"I find the consistency across age, race, BMI, and glycemic status more clinically exciting than the sex difference," said ...
According to a study published in JAMA Network Open, 8.3% of U.S. adults — equivalent to about 21.3 million people — reported ...
An update to the guidelines for urticaria management was published, involving collaboration from various international professional societies.
The 2025 IDSA guidelines provide a comprehensive update on the management of cUTIs and reflect new evidence aiming to improve ...
After reading the medication abortion label, 88% of participants (n=168) had concordant self-selection on their eligibility ...
Despite the protests of the powerful pro-cannabis lobby, it has now been proved beyond any reasonable doubt that cannabis use ...
Paul Pogba's career in French football has not gone according to plan since his arrival. The French midfielder has seen his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results